Skip Page Header

Home > Cancer in Ireland 1994-2011: annual report of the National Cancer Registry 2014.

National Cancer Registry, Ireland. (2014) Cancer in Ireland 1994-2011: annual report of the National Cancer Registry 2014. Cork: National Cancer Registry, Ireland.

[img]
Preview
PDF (National Cancer Registry 2014)
4MB

Incidence:
• An average of approximately 19,200 invasive (excluding non‐melanoma skin) cancers was diagnosed per year between 2009 and 2011, equivalent to an incidence rate of 425 cases per 100,000 per year.
• Incidence rate was 28% higher in men than in women and cumulative lifetime risk of diagnosis was 1 in 3 for males and 1 in 4 for females.
• Excluding non‐melanoma skin cancers, prostate (3,267 cases per year) and female breast cancer (2,781 cases per year) were the most frequently diagnosed cancers in men and women respectively. Colorectal (2,436 cases per year) and lung (2,165 cases per year) cancers were the 2nd and 3rd most common cancers in both sexes.

Mortality:
• A total of 8,871 deaths from cancer occurred in 2011, equivalent to a mortality rate of 179 deaths per 100,000 per year.
• Cancer was the second leading cause of death in Ireland after diseases of the circulatory system.
• Cancer mortality rate was 38% higher in men than in women and cumulative lifetime risk of death from cancer was 1 in 9 overall.
• Lung cancer (1,848 total deaths in 2011) was the leading cause of cancer death in both sexes representing 18% of female and 23% of male cancer deaths. Female breast, colorectal and prostate cancers represented the next most common cancer deaths and together with lung cancer made up almost half (47%) of all cancer deaths in 2011.

Lung cancer (p.20-21)
Tobacco smoking is well recognized as the main risk factor for lung cancer. Historically, smoking prevalence has been higher in males than in females and this is reflected in their generally higher lung cancer incidence. According to 2012 estimates, incidence rates in Ireland and the UK were broadly similar, with male rates approximately 1.4 times higher than those in women (Table 5.1). However incidence rates for the EU overall were higher for males and lower for females, resulting in male rates in Europe generally being 2.5 times higher than females. Trends of lung cancer incidence have been changing however, with male incidence rates declining and female rates increasing in recent years, a trend observed across many European countries. This is related to shifts in smoking prevalence, notably a rise in female smoking since the 1940’s‐50’s, which has resulted in increases in female lung cancer incidence in more recent years. This trend has been observed in both Ireland and the UK


Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Alcohol, Tobacco / Nicotine
Date
May 2014
Pages
96 p.
Publisher
National Cancer Registry, Ireland
Corporate Creators
National Cancer Registry, Ireland
Place of Publication
Cork
EndNote
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page